Exclusion of the transcription factor Max from the nucleus of retinal ganglion cells is an early, caspase-independent event of programmed cell death following damage to the optic axons. To test whether the loss of nuclear Max leads to a reduction in neuroprotection, we developed a procedure to overexpress Max protein in rat retinal tissue in vivo. A recombinant adeno-associated viral vector (rAAV) containing the max gene was constructed, and its efficiency was confirmed by transduction of HEK-293 cells. Retinal ganglion cells were accessed in vivo through intravitreal injections of the vector in rats. Overexpression of Max in ganglion cells was detected by immunohistochemistry at 2 weeks following rAAV injection. In retinal explants, the preparation of which causes damage to the optic axons, Max immunoreactivity was increased after 30 h in vitro, and correlated with the preservation of a healthy morphology in ganglion cells. The data show that the rAAV vector efficiently expresses Max in mammalian retinal ganglion cells, and support the hypothesis that the Max protein plays a protective role for retinal neurons.
The transcription factor Max is a basic helix-loop-helix/leucine zipper protein, which forms heterodimers with members of the Myc protein family (1) . Myc/Max heterodimers exhibit sequence-specific DNA binding and function as transcription factors. Max may also form homodimers which recognize the same DNA target sequence as Myc/Max, but which are unable to function as transcriptional activators (2) . The functional data support a dual physiological role for Max, either as an obligatory DNA-binding partner for Myc, or as a negative regulator of Myc activity, depending on the relative concentration of both partners. The transcription factor cMyc regulates both cell proliferation and apoptosis (3) . Deregulated expression of cMyc is sufficient to drive programmed cell death in response to growth inhibitory signals, but the precise mechanisms are still unclear (4) .
Recently,we showed that the transcrip-tion factor Max, which is found mostly within the nucleus of normal cells, undergoes exclusion from the nucleus early upon induction of programmed cell death in retinal ganglion cells, followed by complete loss of Max immunoreactivity as apoptotic cell death proceeds (5) . The early nuclear exclusion of Max probably leads to the loss of its transcriptional regulatory activity, which may be an early and necessary step for the execution of cell death (5) . Max is ubiquitously expressed and its absence leads to early embryonic lethality (6) . It has been shown that the selective over-expression of Max in endothelial cells blocks apoptosis promoted by serum withdrawal (7) (8) . Gene transfer vectors based on AAV combine a number of advantages: AAV is naturally defective for replication and is considered nonpathogenic (9) . It can transduce both proliferating and post-mitotic cells, transfer a gene to a number of cell types efficiently, and mediate long-term gene expression in the central nervous system, including the retina, as well as in the lungs, liver, or muscle cells, with minimal toxicity and cellular immune responses (10) . A disadvantage of AAV is the limited packaging size of the virus, which cannot exceed 5,000 nucleotides. This, however, is not relevant for the delivery of Max, which is encoded by a relatively small gene.
Recombinant AAV (rAAV) vectors have been proved suitable for long-term transgene expression in the eye (11) , and have been used to transfect a variety of retinal cell types including photoreceptors (12) , retinal pigment epithelial cells (13) , Müller cells (12) , and retinal ganglion cells (14) . The efficiency of transfection of particular cell types in the eye is determined by a number of variables including the site of injection, the AAV serotype and titer, and the specific gene promoter and enhancing elements used. The experiments described below employed an AAV containing the max gene, and capable of efficient transduction of retinal ganglion cells in vivo leading to overexpression of the Max protein.
rAAV stocks were produced by co-transfection of both an rAAV vector plasmid and a helper plasmid containing only minimally required AAV and adenovirus sequences, into HEK-293 cells. The vector plasmid has the pTR-UF backbone (15) containing the max gene under the control of a hybrid CMV/ CBA promoter, all flanked by AAV2 inverted terminal repeats, the only AAV sequence necessary in cis, and functions as the origin of DNA replication and the packaging signal (16) (Figure 1A) . After 72 h the cells were lysed and centrifuged and the vectorcontaining supernatant was centrifuged in an Iodixanol density gradient to separate the vectors from cell debris. The vector fraction was further purified and concentrated by column chromatography. Vector titers were determined by quantitative PCR relative to a known standard and vector purity was assayed by protein gel analysis (17) . All the steps cited above were carried out to assure that the high titer vector stocks were separated from impurities.
To determine the efficiency of transduction of the AAV-max vector, HEK-293 cells (2 x 10 6 ) were infected with 2 x 10 13 par-ticles/ml. Four days after infection, the cells were analyzed by confocal microscopy following immunocytochemistry for Max protein. To obtain photomicrographs representative of the relative intensity of immunolabeling in the various experimental groups, the confocal microscope was set for the most intensely stained image, and all photomicro- To assess the ability of rAAV-max to transduce nervous tissue in vivo, retinal ganglion cells were targeted in newborn rats via intravitreal injection. Each eye received 1 µl of the rAAV-max stock, which represents 2 x 10 10 vector particles. Because there is a delay in rAAV-mediated transgene expression due to the time required for conversion of the recombinant viral DNA to a transcriptionally active double-stranded form (18), In sections of the infected postnatal day 15 retina, there was increased immunoreactivity for Max relative to uninfected retinas ( Figure 1D,E) . Ganglion cells, which were distinguished from other cells within the ganglion cell layer by staining with an antibody to ßIII-tubulin, were highly immunoreactive for Max ( Figure 1D-F) , showing efficient transduction of the rAAV-max vector in these cells. Dissection of retinal tissue for preparation of explants necessarily damages optic nerve axons that originate in the ganglion cells. To test the effect of rAAV-max transduction in such axotomized retinal ganglion cells, infected retinal explants were maintained in vitro for 30 h after dissection. The retinas exhibited increased Max immunostaining after 30 h in vitro compared with uninfected retinas (Figure 2A,B) . Double labeling of both DNA fragmentation with the TUNEL procedure, and Max by immunohistochemistry ( Figure 2C,D) , showed that all TUNEL-positive cells were devoid of Max staining, as previously shown (5). However, cells with intense immunoreactivity for Max still showed an apparently healthy morphology even at 30 h after axon damage ( Figure 2C ), suggesting that overexpression of Max may have a protective effect upon the axotomized ganglion cells.
A surprisingly deleterious effect on retinal survival was described for the protooncogene Bcl-2. Retina infected with AAV containing Bcl-2 was more susceptible to ganglion cell loss than control retina following either axon injury or intravitreal NMDA (19) . This result was unexpected, because Bcl-2 had been shown to have a protective effect both in transgenic models and in vitro. The paradoxical effect of Bcl-2 upon overexpression highlights the importance of carefully examining the results of modulation of gene expression in vivo, particularly in complex tissues such as the retina and other parts of the central nervous system. Viral vectors are efficient gene transfer vehicles in various tissues both in vitro and in vivo. Four main groups of viral vectors are currently used in gene transfer protocols: retroviral, adenoviral, adeno-associated viral, and lentiviral vectors. We choose rAAVmediated gene transfer both because it results in persistent transgene expression and because rAAV is able to infect a variety of cell types, including postmitotic neurons such as the retinal ganglion cells. The purification of rAAV vectors is important to produce highly concentrated stocks, without either cell remnants or serum proteins that might trigger immune responses. We were able to produce stocks of 10 13 particles/ml that, after intravitreal injection into rats, showed no signs of stimulating an immune response.
The experiments reported here demonstrate that rAAV vectors containing the max cDNA were a) infective and drove the expression of the Max protein in both the HEK-293 cell line and in retinal ganglion cells in vivo, and b) showed a potential protective function for retinal ganglion cells. The results support the hypothesis that the early nuclear exclusion of Max from axon-damaged ganglion cells may be a necessary step for the execution of retrograde degeneration (5) , and raise the possibility that modulation of the expression of this transcription factor may be a novel target for the development of gene-based therapy for degenerative retinopathies such as glaucoma, that targets retinal ganglion cells (20) .
